Nothing has changed other than the SP7 Sep 2023 11:00
I appreciate the frustration re the lack of updates but if there’s nothing to tell, how can JC issue an RNS?
Based on what we know today, various projects remain ‘in play’ and TR is due to come on stream in H2.
It’s been said 100 times already, BOD is not an investment for the inpatient (not sure any investment is for the inpatient or those that are driven by emotion /gut feel rather than fact..!)
I’ve been here a long time now but many have held for a lot longer than me. I am (relatively speaking) heavily invested as I still believe BOD is very undervalued and has been for some time. The potential at TR is significant (‘company maker’ or not) and you just need to walk back through previous presentations to gauge the potential in the other projects.
Yes, it could fall flat on its face but I have as much faith in JC and the team to deliver as I did the day I first invested in the company.
Whether the SP is at .75 or 1.15 it really doesn’t matter to me. It’s when we get to the 4,5,6+ I’ll need to start to make decisions around selling.